Nerviano, Italy

Nicola Carfagna


Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Milan, IT (2000)
  • Nerviano, IT (1993 - 2001)

Company Filing History:


Years Active: 1993-2001

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Nicola Carfagna: Innovator in Antineurodegenerative Compounds

Introduction

Nicola Carfagna is a notable inventor based in Nerviano, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antineurodegenerative compounds. With a total of five patents to his name, Carfagna's work has had a meaningful impact on medical science.

Latest Patents

One of Carfagna's latest patents includes the development of Abeo-ergoline derivatives as 5HT1A ligands. This patent describes compounds with specific formulas, where various groups can be substituted to create effective pharmaceutical compositions. These compounds are designed to target neurodegenerative conditions, showcasing Carfagna's commitment to advancing healthcare through innovative solutions.

Career Highlights

Throughout his career, Nicola Carfagna has worked with prominent companies in the pharmaceutical industry. Notable among these are Farmitalia Carlo Erba S.r.l. and Pharmacia & Upjohn S.p.a. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research.

Collaborations

Carfagna has collaborated with esteemed colleagues such as Mario Varasi and Sergio Mantegani. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Nicola Carfagna's contributions to the field of pharmaceuticals, particularly in the area of antineurodegenerative compounds, highlight his role as a significant inventor. His patents and collaborations reflect a dedication to improving medical treatments and advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…